Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial

Hee-Soo HAN; Sung-Hee CHO; Moon-Seok PARK; Ki-Hyuk SUNG; Kyoung-Min LEE.
Journal of Bone Metabolism ; : 131-137, 2021.
Artículo en Inglés | WPRIM | ID: wpr-898938

Documentos relacionados

  1. Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial
  2. Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial.
  3. Comparative study of the effects of osteoprotegerin and testosterone on bone quality in male orchidectomised rats.
  4. Metabolic characteristics of subjects with spine-femur bone mineral density discordances: the Korean National Health and Nutrition Examination Survey (KNHANES 2008-2011).
  5. The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis.
  6. Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
  7. Effects of combined treatment with ibandronate and pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats.
  8. Effects of long-term voluntary wheel running and selective breeding for wheel running on femoral nutrient canals.
  9. Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.
  10. Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.